Literature DB >> 3042307

Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.

P J Koskinen1, J S Viikari, K M Irjala.   

Abstract

Basal, postprandial (2 h after breakfast), and glucagon-stimulated plasma C-peptide concentrations were determined in a group of 36 adult diabetic patients. Basal and postprandial C-peptide values were measured on consecutive days to estimate the degree of variation of C-peptide secretion. In a subgroup of 15 diabetic patients treated chronically with diet and oral hypoglycemic agents (sulfonylureas or a combination of sulfonylureas and metformin), we studied whether administration of sulfonylureas immediately before breakfast had any effect on postprandial C-peptide values. Absolute differences between two consecutive fasting C-peptide concentrations in insulin-requiring patients were less than 0.1 nM in all but 1 patient, in whom the difference was 0.18 nM. In subjects treated with oral hypoglycemic agents the median difference was 0.12 nM (range 0-0.38 nM). Absolute differences between two consecutive postprandial C-peptide concentrations were all less than 0.1 nM in insulin-requiring patients. No significant difference was found between postprandial C-peptide concentrations with or without preceding administration of oral hypoglycemic agents (medians 1.35 and 1.30 nM, respectively). Glucagon-stimulated C-peptide concentrations were somewhat higher than the postprandial values. However, equal discrimination between insulin-requiring and non-insulin-requiring diabetic patients was found by measuring postprandial or glucagon-stimulated C-peptide concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042307     DOI: 10.2337/diacare.11.4.318

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.

Authors:  Seung Won Lee; Sangheun Lee; Se Hwa Kim; Tae Ho Kim; Byung Soo Kang; Seung Hoon Yoo; Min Kyung Lee; Won Jun Koh; Won Sik Kang; Hyeong Jin Kim
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

2.  Analysis of factors influencing postprandial C-peptide levels in Japanese patients with type 2 diabetes: Comparison with C-peptide levels after glucagon load.

Authors:  Shogo Funakoshi; Shimpei Fujimoto; Akihiro Hamasaki; Hideya Fujiwara; Yoshihito Fujita; Kaori Ikeda; Shiho Takahara; Yutaka Seino; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2011-11-30       Impact factor: 4.232

Review 3.  A Practical Review of C-Peptide Testing in Diabetes.

Authors:  Emma Leighton; Christopher Ar Sainsbury; Gregory C Jones
Journal:  Diabetes Ther       Date:  2017-05-08       Impact factor: 2.945

4.  EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature.

Authors:  Timothy J McDonald; Mandy H Perry; Roy W A Peake; Nicola J Pullan; John O'Connor; Beverley M Shields; Beatrice A Knight; Andrew T Hattersley
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.